A phase I clinical trial of intrathecal injection of allogeneic CAR-γδT cells targeting B7H3 for the treatment of patients with recurrent glioblastoma

QH104 - Beijing Qinghui Liannuo Biotechnology

X. Li1; W. Ma2; Y. Gu3; Y. Sui4; X. zhang1; C. wang1; W. Gan5; J. chen6; L. wang7; Y. zhang8; Y. zhang9; Y. Huang1

Jul 16, 2024